Diagnosis of IgG4 related arthritis is a dubious disease in the field of autoimmunity and rheumatic immunity, clinical performance is complex and often involves multi-systematic strain. Early identification and standardized diagnosis are critical to improving prognosis. Diagnosis of the disease requires a combination of clinical performance, imaging inspection, laboratory testing and pathological evaluation.
The platform can assist in matching teams of authoritative experts at home and abroad to provide accurate diagnosis and treatment programs. In recent years, with the development of therapeutic, immune-regulatory therapy and precision medicine, many autoimmune and rheumatic immune disorders that were previously difficult to treat have been significantly improved. Treatment needs to be closely monitored for efficacy and adverse reactions, adapted to timely schemes according to changes in the condition.
Multidisciplinary collaboration (MDT) is especially important for the integrated management of IgG4-related adenitis. The platform serves a team of internationally authoritative experts in the field of autoimmune and rheumatic immunity in China, providing the following services to patients: 2. Visiting China: arranging face-to-face treatment with authoritative experts, developing individualized treatment programs; 3.
Full-service: providing one-stop services such as medical translation, medical care, accommodation arrangements; 4. Long-term follow-up: establishing a chronic disease management archive, continuous monitoring of disease changes and treatment effects.